1. 2085. PrEP Interest and Preferences Among US Black and Hispanic Men – A National Survey. (15th December 2022) Authors: Poteat, Tonia; Sarkar, Supriya; Ragone, Leigh; Rawlings, Keith; Rinehart, Alex R; Hill, Jennifer N; Gallington, Kyli; Coyne, Karin S; Vannappagari, Vani Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2089. Relative patient preferences for starting daily, on-demand, and long-acting injectable HIV pre-exposure prophylaxis among US men who have sex with men, 2021-2022. (15th December 2022) Authors: Sanchez, Travis; Wilson Beckham, S; Hannah, Marissa J; Winslow Edwards, O; Rawlings, Keith; Rinehart, Alex R; Sarkar, Supriya; Sullivan, Patrick S; Vannappagari, Vani Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 795. Awareness and Interest in PrEP Options Among US Cisgender Women – A National Survey. (15th December 2022) Authors: Poteat, Tonia; Sarkar, Supriya; Ragone, Leigh; Rawlings, Keith; Rinehart, Alex R; Hill, Jennifer N; Gallington, Kyli; Coyne, Karin S; Vannappagari, Vani Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. African Tick Bite Fever Treated Successfully With Rifampin in a Patient With Doxycycline Intolerance. (13th May 2017) Authors: Strand, Andrew; Paddock, Christopher D; Rinehart, Alex R; Condit, Marah E; Marus, Jessica R; Gillani, Shezeen; Chung, Ida H; Fowler, Vance G Journal: Clinical infectious diseases Issue: Volume 65:Number 9(2017) Page Start: 1582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention. (14th October 2022) Authors: Eshleman, Susan H; Fogel, Jessica M; Halvas, Elias K; Piwowar-Manning, Estelle; Marzinke, Mark A; Kofron, Ryan; Wang, Zhe; Mellors, John; McCauley, Marybeth; Rinehart, Alex R; St Clair, Marty; Adeyeye, Adeola; Hinojosa, Juan C; Cabello, Robinson; Middelkoop, Keren; Hanscom, Brett; Cohen, Myron S;... Journal: Journal of infectious diseases Issue: Volume 226:Number 12(2022) Page Start: 2170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial. Issue 8 (August 2017) Authors: Markowitz, Martin; Frank, Ian; Grant, Robert M; Mayer, Kenneth H; Elion, Richard; Goldstein, Deborah; Fisher, Chester; Sobieszczyk, Magdalena E; Gallant, Joel E; Van Tieu, Hong; Weinberg, Winkler; Margolis, David A; Hudson, Krischan J; Stancil, Britt S; Ford, Susan L; Patel, Parul; Gould, Elizabe... Journal: Lancet Issue: Volume 4:Issue 8(2017) Page Start: e331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial. Issue 7 (July 2020) Authors: Landovitz, Raphael J; Li, Sue; Eron, Joseph J; Grinsztejn, Beatriz; Dawood, Halima; Liu, Albert Y; Magnus, Manya; Hosseinipour, Mina C; Panchia, Ravindre; Cottle, Leslie; Chau, Gordon; Richardson, Paul; Marzinke, Mark A; Eshleman, Susan H; Kofron, Ryan; Adeyeye, Adeola; Burns, David; Rinehart, Al... Journal: Lancet Issue: Volume 7:Issue 7(2020) Page Start: e472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗